Invesco
BVS icon

Invesco’s Bioventus BVS Stock Holding History

Invesco’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
26,103
-8,695
-25% -$83K ﹤0.01% 3509
2026
Q1 		$318K Buy
34,798
+1,177
+4% +$9.87K ﹤0.01% 3315
2025
Q4 		$250K Buy
33,621
+11,639
+53% +$83.7K ﹤0.01% 3456
2025
Q3 		$147K Sell
21,982
-1,000
-4% -$6.94K ﹤0.01% 3622
2025
Q2 		$152K Sell
22,982
-245,046
-91% -$1.74M ﹤0.01% 3582
2025
Q1 		$2.45M Buy
268,028
+248,932
+1,304% +$2.49M ﹤0.01% 2464
2024
Q4 		$201K Sell
19,096
-323,850
-94% -$3.83M ﹤0.01% 3515
2024
Q3 		$4.1M Buy
342,946
+319,681
+1,374% +$2.76M ﹤0.01% 2338
2024
Q2 		$134K Buy
+23,265
New +$128K ﹤0.01% 3712
2023
Q1 		– Sell
-24,896
Closed -$65K – 3878
2022
Q4 		$65K Buy
24,896
+13,274
+114% +$58K ﹤0.01% 3887
2022
Q3 		$81K Sell
11,622
-118
-1% -$924 ﹤0.01% 3866
2022
Q2 		$81K Buy
11,740
+942
+9% +$9.61K ﹤0.01% 3919
2022
Q1 		$153K Buy
10,798
+435
+4% +$5.82K ﹤0.01% 3816
2021
Q4 		$150K Buy
+10,363
New +$147K ﹤0.01% 3840

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's BVS Position: Q2 2026 in Review

Invesco reduced its Bioventus (BVS) stake by 25% in Q2 2026, selling an estimated $83K and leaving 26,103 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

Invesco first reported a position in BVS in Q4 2021 and has held it in 14 quarters since. The position peaked at $4.1M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Invesco held 26,103 shares of Bioventus worth $246K as of Q2 2026.
  • Invesco sold 8,695 Bioventus shares in Q2 2026, an estimated $83K.
  • Bioventus made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3509 holding.
  • Invesco first reported a position in Bioventus in Q4 2021 and has held it in 14 quarters since.
  • Invesco's Bioventus position peaked at $4.1M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.